Qvents
Discussion forum for Pharma Quality events, Regulatory Actions
Home
About Us
Contact Us
Expert Panel
Tags
Qvents
Warning Letters
483s
Recalls
Import Alerts
Quality Insights
Tags
Forums
Learning Resources
Upcoming Trainings
Training Archives
Guidelines
Pharma Jobs
Job Openings
Post a Job
Jobs posted by me
Users & Profiles
News
Login/Register
Individual
Company
Home
About Us
Contact Us
Expert Panel
Tags
Qvents
Warning Letters
483s
Recalls
Import Alerts
Quality Insights
Tags
Forums
Learning Resources
Upcoming Trainings
Training Archives
Guidelines
Pharma Jobs
Job Openings
Post a Job
Jobs posted by me
Users & Profiles
News
Login/Register
Tag:
Thomas J Arista
FDA Warning letter to Zydus: Previous Re
USFDA Inspection at Cadila Ahmedabad, India in April-May 2019 by Investigators Justin A Boyd, Thomas
Qvents
June 23, 2023
Facebook
LinkedIn
Twitter
Search Posts
Latest Posts
Nitrosamine Impurities in Pharmaceutical Products: Templates for Risk Assessment and Supplier Evaluation
April 9, 2025
USFDA 483 Cites Piramal Pharma for Investigation Deficiencies, Procedural Non-Compliance
March 13, 2025
Contamination Control and Data Integrity Issues: Granules India Receives USFDA Warning Letter
March 7, 2025
Janssen’s Korea Vaccine Unit USFDA 483 Cites Aseptic Operations Not in Control
February 26, 2025
Facility Registration Violations, Refusal of Inspection: Jagsonpal Issued Warning letter
February 22, 2025
